Estudios

William B. Feldman, MD, DPhil, MPH; Jerry Avorn, MD; Aaron S. Kesselheim, MD, JD, MPH; Joshua J. Gagne, PharmD, ScD. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers. JAMA Internal Medicine July 2023 Volume 183, Number 7 CONCLUSION In this cohort study, LAMA-LABA therapy was associated with improved clinical outcomes compared with ICS-LABA therapy, suggesting that LAMA-LABA therapy should be preferred for patients with COPD

Presenta Dra. María José Correales

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment. Lancet 2021; 398: 1894–904. Interpretation A geriatric assessment intervention for older patients with advanced cancer reduced serious toxic effects from cancer treatment. Geriatric assessment with management should be integrated into the clinical care of older patients with advanced cancer and ageing-related conditions.

Presenta Dr. Matías Ríos

Mankikian J, Caille A, Reynaud-Gaubert M, et al. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial. Eur Respir J 2023; 61: 2202071 Interpretation Combination of rituximab and MMF was superior to MMF alone in patients with ILD and a NSIP pattern. The use of this combination must take into consideration the risk of viral infection

Presenta Dr. Felipe Cayupi

Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for OSA Data From a Large Multicenter French Cohort. CHEST 2020; 158(6):2610-2620. I NTERPRETATION: Nocturnal hypoxemia was associated with all-cancer incidence in patients investigated for OSA. Whether OSA therapy might reduce the risk of cancer needs further evaluation

Presenta Dra. María Belén Fernández

Patrick W. Sullivan. Association Between Pulmonary Function and Asthma Symptoms. J ALLERGY CLIN IMMUNOL PRACT SEPTEMBER/OCTOBER 2019

Presenta Dr. Max Kauffmann